Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998;77(1):1–10. doi: 10.1038/bjc.1998.1

United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).

PMCID: PMC2151254  PMID: 9459138

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balls M. Replacement of animal procedures: alternatives in research, education and testing. Lab Anim. 1994 Jul;28(3):193–211. doi: 10.1258/002367794780681714. [DOI] [PubMed] [Google Scholar]
  2. Bibby M. C., Double J. A., Ali S. A., Fearon K. C., Brennan R. A., Tisdale M. J. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. J Natl Cancer Inst. 1987 Mar;78(3):539–546. [PubMed] [Google Scholar]
  3. Burtles S. S., Newell D. R., Henrar R. E., Connors T. A. Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office. Eur J Cancer. 1995;31A(3):408–410. doi: 10.1016/0959-8049(94)00483-l. [DOI] [PubMed] [Google Scholar]
  4. Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A., Jr, Butel J. S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992 Mar 19;356(6366):215–221. doi: 10.1038/356215a0. [DOI] [PubMed] [Google Scholar]
  5. Festing M. F. Reduction of animal use: experimental design and quality of experiments. Lab Anim. 1994 Jul;28(3):212–221. doi: 10.1258/002367794780681697. [DOI] [PubMed] [Google Scholar]
  6. Flecknell P. A. Refinement of animal use--assessment and alleviation of pain and distress. Lab Anim. 1994 Jul;28(3):222–231. doi: 10.1258/002367794780681660. [DOI] [PubMed] [Google Scholar]
  7. HUGGINS C., BRIZIARELLI G., SUTTON H., Jr Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med. 1959 Jan 1;109(1):25–42. doi: 10.1084/jem.109.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hollingshead M. G., Alley M. C., Camalier R. F., Abbott B. J., Mayo J. G., Malspeis L., Grever M. R. In vivo cultivation of tumor cells in hollow fibers. Life Sci. 1995;57(2):131–141. doi: 10.1016/0024-3205(95)00254-4. [DOI] [PubMed] [Google Scholar]
  9. Kallman R. F., Brown J. M., Denekamp J., Hill R. P., Kummermehr J. The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop. Cancer Res. 1985 Dec;45(12 Pt 1):6541–6545. [PubMed] [Google Scholar]
  10. Kripke M. L., Gruys E., Fidler I. J. Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res. 1978 Sep;38(9):2962–2967. [PubMed] [Google Scholar]
  11. Mahon K. A., Chepelinsky A. B., Khillan J. S., Overbeek P. A., Piatigorsky J., Westphal H. Oncogenesis of the lens in transgenic mice. Science. 1987 Mar 27;235(4796):1622–1628. doi: 10.1126/science.3029873. [DOI] [PubMed] [Google Scholar]
  12. Martin D. S., Balis M. E., Fisher B., Frei E., Freireich E. J., Heppner G. H., Holland J. F., Houghton J. A., Houghton P. J., Johnson R. K. Role of murine tumor models in cancer treatment research. Cancer Res. 1986 Apr;46(4 Pt 2):2189–2192. [PubMed] [Google Scholar]
  13. Morton D. B., Griffiths P. H. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Rec. 1985 Apr 20;116(16):431–436. doi: 10.1136/vr.116.16.431. [DOI] [PubMed] [Google Scholar]
  14. Moser A. R., Pitot H. C., Dove W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990 Jan 19;247(4940):322–324. doi: 10.1126/science.2296722. [DOI] [PubMed] [Google Scholar]
  15. Nordsmark M., Maxwell R. J., Wood P. J., Stratford I. J., Adams G. E., Overgaard J., Horsman M. R. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy. Br J Cancer Suppl. 1996 Jul;27:S232–S235. [PMC free article] [PubMed] [Google Scholar]
  16. Redgate E. S., Deutsch M., Boggs S. S. Time of death of CNS tumor-bearing rats can be reliably predicted by body weight-loss patterns. Lab Anim Sci. 1991 Jun;41(3):269–273. [PubMed] [Google Scholar]
  17. Roush W. Hunting for animal alternatives. Science. 1996 Oct 11;274(5285):168–171. doi: 10.1126/science.274.5285.168. [DOI] [PubMed] [Google Scholar]
  18. Twentyman P. R., Brown J. M., Gray J. W., Franko A. J., Scoles M. A., Kallman R. F. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst. 1980 Mar;64(3):595–604. [PubMed] [Google Scholar]
  19. Wood P. J., Stratford I. J., Sansom J. M., Cattanach B. M., Quinney R. M., Adams G. E. The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31P magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys. 1992;22(3):473–476. doi: 10.1016/0360-3016(92)90856-d. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES